Silicon Investor (SI) -- The First Internet Community

discover

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Sharck Soup -- Ignore unavailable to you. Want to Upgrade?

To: JustTradeEm who wrote (37689)	5/12/2002 1:21:10 PM
From: Sharck	Read Replies (1) \| Respond to of 37746

You're busted JBSCUMBAG... What'sa matter JBboy, you knowing lie and then think a small one week suspension will allow me to forget... Here is a perfect example of your credibility at stake. You said that I was a pop up ad, recruiting on Toms site. If that were true, then I am sure you clicked on my name, and saw every so called post in reference to our site. Well guess what, here is every single post I made leading up to the reply to OVER, and NOT a single one in reference to my p-site, in fact the P-SITE wasnt even private until May 1: Making BREAD! By: Sharck 27-Jan-02 06:42 AM TOM, Quick question, its 5 AM EST, and I "kneed" to have a loaf of bread made in 3 hours. Is it true whole wheat flour must sit before heating? Sharck More ROOM By: Sharck 28-Jan-02 07:52 AM ROOM beats, expect a SS squeegy pop... Chip Warnings By: Sharck 29-Jan-02 03:20 PM TOSHIBA, FUJITSU warn in Asian mkts... Pharmacia By: Sharck 08-Feb-02 06:34 AM biz.yahoo.com health_pharmacia_dc_1.html Friday February 8, 7:33 am Eastern Time Pharmacia: Cancer Drug Not Effective PEAPACK, N.J. (Reuters) - Drugmaker Pharmacia Corp. (NYSE:PHA - news) on Friday said it was halting late-stage clinical trials of an experimental colorectal cancer drug because the treatment was unlikely to reach its goals. Bristol Wants $2B ImClone Deal Cut By: Sharck 08-Feb-02 07:56 AM biz.yahoo.com bristol_2.html Bristol Wants $2B ImClone Deal Cut Bristol-Myers Wants $2 Billion Deal With Biotech Co. ImClone Cut Nearly in Half, Source Says By PAUL ELIAS AP Biotechnology Writer SAN FRANCISCO (AP) -- A soured drug partnership with ImClone Systems Inc. has led Bristol-Myers Squibb Co. [NYSE:BMY - news] to demand its $2 billion deal with the biotechnology company ImClone Systems Inc. be cut nearly in half, according to a source close to the deal. Stagnation By: Sharck 03-Apr-02 11:29 AM Stagnation: Been awhile since we heard that term. However, I believe it is unjustified in the present conditions and here is why. The inflation component is based on energy prices, which are directly related to middle east tensions and NOT to supply and demand. INfact today we have a report of 6.5 million barrels of inventory suggesting a disconnect with economic reality. Mkts still riding on the backs of consumers and not capex, as seen by PSFTs report. Sources tell me that we are on for another rumble with Saddam which could certainly shift any potential recovery out by another Q. Other sources in the telco space tell me that orders are still down. Agree with Tom, the only spike will come from the nonfarm payroll number but may be short lived. Tom, let me know too, how I can assist you on your site., All the best, S jobs By: Sharck 05-Apr-02 06:43 AM Gm all, UI numbers out in Canada and as expected, quite a few jobs have been added over the session. Futs pop, 2year yields up 14 base pts... S OSIS By: Sharck 05-Apr-02 09:15 AM Hi Tom, Can I ask you what news you are expecting on OSIS, and when. Thanks much. S B2B By: Sharck 22-Apr-02 02:31 PM Hi guys, anyone got an EST on Book to Bill for me? Thanks much S abx By: Sharck 22-Apr-02 04:32 PM Barricks gold to announce major news tomorrow 9 AM EST ... BIOS By: Sharck 25-Apr-02 01:25 PM HEAVY SELLING HERE IN THE BTK< could haul the rest of the mkts lower... OVER FLOAT 44.4M By: Sharck 26-Apr-02 08:12 AM

Copyright/IP Policy

Advertise on SI

© 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News